CRP and COVID-19: The marker of inflammation, C reactive protein, was also higher in the COVID-19 group, median 78 (5.5, 208.5) vs. 22.6 (15.4, 61.8), p = 0.02, as well as a tissue damage biomarker median, LDH 563 (446.5, 812) vs. 292 (275.7, 573.5), p = 0.01 (Table 3).